World Media Directory · RSS · Email Newsletters

There were 1,653 press releases posted in the last 24 hours and 350,791 in the last 365 days.

Healthcare & Pharmaceuticals Industry Press Releases

Healthcare & Pharmaceuticals Industry Press Releases Distributed by EIN Presswire

206,992 Press Releases · RSS · Email

Published on February 2, 2023 - 13:02 GMT

Pliant Therapeutics Announces FDA Clearance of Investigational New Drug Application for PLN-101095, A Novel Integrin Inhibitor for ...

SOUTH SAN FRANCISCO, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a clinical stage biotechnology company focused on discovering and developing novel therapeutics for the treatment of fibrosis, today announced that the …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on February 2, 2023 - 13:01 GMT

Promex Further Extends Die-Bonding Proficiencies

SANTA CLARA, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Promex Industries, a Silicon Valley–based provider of advanced design, packaging, and microelectronics assembly services, today announced the next key addition to its die-bonding service capabilities: …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on February 2, 2023 - 13:01 GMT

Gradalis to Present at the 2023 BIO CEO & Investor Conference

DALLAS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Gradalis, Inc., a privately held, late-stage clinical biotechnology company developing a personalized immunotherapy called Vigil® for patients with ovarian and other cancer tumor types, today announced that Steven …

Distribution channels: Conferences & Trade Fairs, Healthcare & Pharmaceuticals Industry ...
Published on February 2, 2023 - 13:00 GMT

Singular Genomics Joins the 10x Genomics Compatible Partner Program

– Demonstrates compatibility of the G4 Sequencing Platform with 10x Genomics Single Cell Applications – SAN DIEGO, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on February 2, 2023 - 13:00 GMT

Centessa Pharmaceuticals Announces Presentation at the SVB Securities Global Biopharma Conference

BOSTON and LONDON, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company focused on discovering and developing medicines that are transformational for patients, today announced that members …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 2, 2023 - 13:00 GMT

IRADIMED CORPORATION Announces Fourth Quarter and Full Year 2022 Financial Results and Announces Special Cash Dividend

Reports fourth quarter 2022 revenue of $14.9 million, GAAP diluted EPS of $0.29 and non-GAAP diluted EPS of $0.32. Reports full-year 2022 revenue of $53.3 million, GAAP diluted EPS of $1.02 and non-GAAP diluted EPS of $1.10. The Board of Directors approved …

Distribution channels: Business & Economy, Healthcare & Pharmaceuticals Industry ...
Published on February 2, 2023 - 13:00 GMT

Hydreight Technologies Provides Corporate Update

VANCOUVER, British Columbia and LAS VEGAS, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. ("Hydreight" or the "Company") (TSXV: NURS)(FSE: SO6) a fast-growing telehealth platform and medical network enabling flexible home …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on February 2, 2023 - 13:00 GMT

Bionano’s Symposium 2023 Featured Record Numbers of Presentations Demonstrating Applications of OGM Across Cell Bioprocessing and ...

Over 3,000 registrants with attendees from 114 countries Average daily attendance of 750 in 2023 versus 565 in 2022 31 oral presentations delivered across four consecutive days 69 scientific posters featuring optical genome mapping (OGM) on view in the …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on February 2, 2023 - 13:00 GMT

Volta Medical Announces Completion of Patient Enrollment in TAILORED-AF Clinical Trial for Treatment of Atrial Fibrillation

• First randomized controlled clinical trial to evaluate VX1-guided ablation compared to conventional anatomical ablation approaches to treat persistent atrial fibrillation • International, multi-center trial involving 26 sites, 374 patients is expected to …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on February 2, 2023 - 13:00 GMT

Achieve Life Sciences to Participate at the 2023 SVB Securities Global Biopharma Conference

SEATTLE, Wash and VANCOUVER, British Columbia, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmaceutical company committed to the global development and commercialization of cytisinicline for smoking …

Distribution channels: Healthcare & Pharmaceuticals Industry, Media, Advertising & PR ...
Published on February 2, 2023 - 13:00 GMT

Gain Therapeutics to Participate in Upcoming Scientific and Medical Conferences

BETHESDA, Md., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company transforming drug discovery with its proprietary computational discovery platform identifying novel allosteric …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on February 2, 2023 - 13:00 GMT

Mersana Therapeutics to Present at Upcoming Investor Conferences

CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody-drug conjugates (ADCs) targeting cancers in areas of high …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on February 2, 2023 - 13:00 GMT

Protara Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day

NEW YORK, Feb. 02, 2023 (GLOBE NEWSWIRE) -- Protara Therapeutics, Inc. (Nasdaq: TARA), a clinical-stage company developing transformative therapies for the treatment of cancer and rare diseases, today announced that management will participate in a …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on February 2, 2023 - 13:00 GMT

PETVIVO HOLDINGS, INC. TO ANNOUNCE RESULTS FOR THE THIRD QUARTER ENDED DECEMBER 31, 2022

MINNEAPOLIS, MN, US, Feb. 02, 2023 (GLOBE NEWSWIRE) -- PetVivo Holdings, Inc. (NASDAQ: PETV and PETVW), an emerging biomedical device company focused on the commercialization of innovative medical therapeutics for animals, will report financial results on …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 2, 2023 - 12:35 GMT

Reneo Pharmaceuticals to Participate in SVB Securities Global Biopharma Conference

IRVINE, Calif., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Reneo Pharmaceuticals, Inc. (NASDAQ: RPHM), a clinical stage pharmaceutical company focused on the development and commercialization of therapies for patients with rare, genetic, mitochondrial diseases, …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on February 2, 2023 - 12:30 GMT

PharmaTher Holdings Announces FDA Grant of Orphan Drug Designation to KETARX™ (Ketamine) for the Treatment of Rett Syndrome

PharmaTher’s 5th FDA orphan drug designation for KETARX™ (ketamine) Phase 2 clinical study results to support proposed Phase 3 development of KETARX™ (ketamine) to treat Rett Syndrome for FDA approval via the 505(b)(2) regulatory pathway TORONTO, Feb. 02, …

Distribution channels: Healthcare & Pharmaceuticals Industry
Published on February 2, 2023 - 12:30 GMT

Relay Therapeutics to Participate in Guggenheim Healthcare Talks | Oncology Day

CAMBRIDGE, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Relay Therapeutics, Inc. (Nasdaq: RLAY) is scheduled to participate in a fireside chat at the Guggenheim Healthcare Talks | Oncology Day on Thursday, February 9, 2023 at 10:10 a.m. ET. The fireside chat …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...
Published on February 2, 2023 - 12:30 GMT

Xilio Therapeutics to Present at the Guggenheim Healthcare Talks Oncology Day

WALTHAM, Mass., Feb. 02, 2023 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a biotechnology company developing tumor-activated immuno-oncology therapies for people living with cancer, today announced that René Russo, Pharm.D., chief executive …

Distribution channels: Healthcare & Pharmaceuticals Industry ...
Published on February 2, 2023 - 12:05 GMT

Clearside Biomedical Announces Positive 6-Month Results from OASIS Extension Study with Suprachoroidal CLS-AX (axitinib injectable ...

- Suprachoroidal CLS-AX Resulted in Favorable Safety Data, Durability and Biologic Effect Over 6 Months in Treatment-Experienced Anti-VEGF Sub-Responders - - 67% of Extension Study Participants Went at Least 6 Months Without Needing Additional Treatment - …

Distribution channels: Healthcare & Pharmaceuticals Industry, Technology ...
Published on February 2, 2023 - 12:00 GMT

ONL Therapeutics to Present at 2023 BIO CEO & Investor Conference

ANN ARBOR, Mich., Feb. 02, 2023 (GLOBE NEWSWIRE) -- ONL Therapeutics, Inc., a clinical-stage biopharmaceutical company developing novel therapies for protecting the vision of patients with retinal disease, announced today that David Esposito, chief …

Distribution channels: Culture, Society & Lifestyle, Healthcare & Pharmaceuticals Industry ...

Previous 7 8 9 10 11 12 13 14 15 16 17 Next

Don’t miss any breaking news!

Get the EIN Presswire App

Power your mobile with the latest breaking news by country, US state or industry.